PETA science consortium to present non-animal alternatives at FDA tobacco testing workshop

December 04, 2014

Washington, D.C. - A PETA International Science Consortium advisor, Joseph Manuppello, will present the "Animal Protection Perspective" at a workshop sponsored by the U.S. Food and Drug Administration (FDA) intended to identify in vitro models and assays for tobacco toxicity testing.

The workshop, Assessment of In Vitro COPD [Chronic Obstructive Pulmonary Disease] Models for Tobacco Regulatory Science, was designed by the nonprofit laboratory, the Institute for In Vitro Sciences (IIVS), to bring together experts and participants to specifically address the relevant research goals of the FDA's Center for Tobacco Products.

According to IIVS, the research priorities of the Center for Tobacco Products include the identification of in vitro models and assays for assessing tobacco constituent or compound hazards and for comparing the respiratory toxicity of different tobacco products.

Areas to be explored in the workshop include: The introductory session will feature speakers from the FDA's Center for Tobacco Products, tobacco manufacturer R. J. Reynolds, and the PETA International Science Consortium presenting regulatory, industry, and animal protection perspectives.

Manuppello will discuss opportunities for minimizing animal use within the current regulatory environment for tobacco products. "Tobacco products can and must be tested using nonanimal testing methods as the standard, and the FDA must exercise its authority to avoid harming animals," says Manuppello.
The workshop in Bethesda, Maryland will be held December 8-10 at North Bethesda Marriott and Conference Center, 5701 Marinelli Road. For more information about nonanimal testing methods, please visit the PETA International Science Consortium, Ltd., website.

People for the Ethical Treatment of Animals

Related Tobacco Articles from Brightsurf:

UC studies tobacco use, cancer connection
Researchers at the University of Cincinnati have identified new clues into ways tobacco use impacts patients with kidney cancer.

'Best' hospitals should be required to deliver tobacco treatment
A UCLA-led report published today in the Journal of the American Medical Association Internal Medicine exposes what the authors call a weakness in the high-profile 'Best Hospitals Honor Roll' published annually by US News and World Report.

Small shops, heavy advertisers less likely to ID for tobacco
'Our findings suggest that certain types of stores -- tobacco shops, convenience stores and those with a lot of tobacco advertising -- are more likely to sell tobacco to a young person without checking his or her ID.'

Youth smoking and vaping: What does it mean for tobacco control
New research from PIRE/PRC features analysis of in-depth, qualitative interviews with young vapers in California between 15 and 25.

Truth telling about tobacco and nicotine
In 'Truth Telling about Tobacco and Nicotine,' PRC researchers explain that, although there is agreement among researchers about evidence that vaping can be less harmful than combustible cigarettes, the tobacco control community remains divided about how to communicate -- or even whether to communicate -- information about the relative risks of tobacco and nicotine products.

A 'joint' problem: Investigating marijuana and tobacco co-use
A survey of marijuana and tobacco co-users by Medical University of South Carolina investigators found that co-users with high degree of interrelatedness between their use of the two substances had greater tobacco dependence and smoked more cigarettes per day.

How genes affect tobacco and alcohol use
A new study gives insight into the complexity of genetic and environmental factors that compel some of us to drink and smoke more than others.

Tobacco use linked with higher use of opioids and sedatives
Tobacco is a known risk factor for the misuse of prescription opioids.

Changes in flavored tobacco product use among youth tobacco users
Self-reportedĀ use of flavored tobacco products by middle and high school students decreased from 2014 to 2016 but climbed back up in 2017 in an analysis of national survey data.

Heated tobacco product claims by tobacco industry scrutinized by UCSF researchers
Claims by the tobacco industry that heated tobacco products (HTPs) are safer than conventional cigarettes are not supported by the industry's own data and are likely to be misunderstood by consumers, according to research published in a special issue of Tobacco Control.

Read More: Tobacco News and Tobacco Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to